Vmbook Online ordering

Ishares Nasdaq Biotechnology

**iShares Nasdaq Biotechnology ETF (IBB)**

**Exchange:** Nasdaq Stock Market

**Ticker Symbol:** IBB

**Sector:** Biotechnology

**Overview:**

IBB is an exchange-traded fund (ETF) that tracks the Nasdaq Biotechnology Index, providing investors with exposure to a broad range of U.S. biotechnology companies.

**Financial Data:**

* **Assets Under Management:** $12.3 billion (as of August 2023)

* **Expense Ratio:** 0.47%

* **NAV per Share:** $336.48 (as of August 2023)

**Top Holdings:**

* Amgen (AMGN)

* Gilead Sciences (GILD)

* Biogen (BIIB)

* Vertex Pharmaceuticals (VRTX)

* Regeneron Pharmaceuticals (REGN)

**Earnings and Growth:**

* **Trailing Twelve Months (TTM) Earnings Per Share (EPS):** $18.42

* **Earnings Growth Rate (TTM):** 10.5%

* **Five-Year Annualized Earnings Growth Rate:** 12.3%

* **Dividend Yield:** 0.5%

**Performance:**

* **One-Year Return:** 12.5%

* **Three-Year Return:** 25.4%

* **Five-Year Return:** 56.3%

**Other Key Metrics:**

* **P/E Ratio (TTM):** 21.6

* **PEG Ratio:** 1.8

* **Price-to-Book Ratio:** 4.2

* **Beta:** 1.1

**Investment Considerations:**

* IBB provides diversified exposure to the biotechnology sector, which has historically outperformed the broader market.

* The ETF has a strong track record of earnings growth and capital appreciation.

* However, the biotechnology sector is subject to regulatory and scientific risks, which can impact its performance.

* Investors should consider their risk tolerance and investment horizon before investing in IBB.